← FDA Drug Approvals (Drugs@FDA)

STIOLTO RESPIMAT

NDA · New Drug Application · Sponsor: BOEHRINGER INGELHEIM · Approved 2015-05-21

Drug application

FDA Application #

NDA206756

Application type

New Drug Application

Brand name

STIOLTO RESPIMAT

Generic name

TIOTROPIUM BROMIDE AND OLODATEROL

Active ingredients

OLODATEROL HYDROCHLORIDE; TIOTROPIUM BROMIDE

Dosage form

SPRAY, METERED

Route

INHALATION

Marketing status

Prescription

Sponsor

BOEHRINGER INGELHEIM

Manufacturer

Boehringer Ingelheim Pharmaceuticals, Inc.

First approval

2015-05-21

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown